(Q38038846)

English

2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management

scientific article published on September 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

27 August 2017

2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management. (English)

1 reference

Europe PubMed Central

27 August 2017

0 references

Kenneth Dickstein

19

object named as

Kenneth Dickstein

0 references

Carina Blomström-Lundqvist

40

object named as

Carina Blomström-Lundqvist

1 reference

Europe PubMed Central

27 August 2017

object named as

Bruce L Wilkoff

37

0 references

object named as

Cecilia Linde

26

0 references

European Society of Cardiology

2

object named as

European Society of Cardiology (ESC)

1 reference

Europe PubMed Central

27 August 2017

Heart Rhythm Society

3

object named as

Heart Rhythm Society

1 reference

Europe PubMed Central

27 August 2017

Frank Ruschitzka

49

object named as

Frank Ruschitzka

1 reference

Europe PubMed Central

27 August 2017

Angelo Auricchio

12

object named as

Angelo Auricchio

1 reference

Europe PubMed Central

27 August 2017

42

object named as

Hugh Calkins

1 reference

Europe PubMed Central

27 August 2017

Richard A. Grimm

22

object named as

Richard A Grimm

1 reference

Europe PubMed Central

27 August 2017

Carsten W. Israel

24

object named as

Carsten Israel

1 reference

Europe PubMed Central

27 August 2017

36

object named as

Panos E Vardas

1 reference

Europe PubMed Central

27 August 2017

Jean-Claude Daubert

9

object named as

Jean-Claude Daubert

1 reference

Europe PubMed Central

27 August 2017

Christophe Leclercq

25

object named as

Christophe Leclercq

1 reference

Europe PubMed Central

27 August 2017

31

object named as

Frits Prinzen

1 reference

Europe PubMed Central

27 August 2017

20

object named as

Derek V Exner

1 reference

Europe PubMed Central

27 August 2017

author name string

European Heart Rhythm Association (EHRA)

1

1 reference

Europe PubMed Central

27 August 2017

Heart Failure Society of America (HFSA)

4

1 reference

Europe PubMed Central

27 August 2017

American Society of Echocardiography (ASE)

5

1 reference

Europe PubMed Central

27 August 2017

American Heart Association (AHA)

6

1 reference

Europe PubMed Central

27 August 2017

European Association of Echocardiography (EAE) of ESC

7

1 reference

Europe PubMed Central

27 August 2017

Heart Failure Association of ESC (HFA)

8

1 reference

Europe PubMed Central

27 August 2017

Leslie Saxon

10

1 reference

Europe PubMed Central

27 August 2017

Philip B Adamson

11

1 reference

Europe PubMed Central

27 August 2017

Ronald D Berger

13

1 reference

Europe PubMed Central

27 August 2017

John F Beshai

14

1 reference

Europe PubMed Central

27 August 2017

Ole Breithard

15

1 reference

Europe PubMed Central

27 August 2017

Michele Brignole

16

1 reference

Europe PubMed Central

27 August 2017

John Cleland

17

1 reference

Europe PubMed Central

27 August 2017

David B DeLurgio

18

1 reference

Europe PubMed Central

27 August 2017

Michael Gold

21

1 reference

Europe PubMed Central

27 August 2017

David L Hayes

23

1 reference

Europe PubMed Central

27 August 2017

JoAnn Lindenfeld

27

1 reference

Europe PubMed Central

27 August 2017

Bela Merkely

28

1 reference

Europe PubMed Central

27 August 2017

Lluis Mont

29

1 reference

Europe PubMed Central

27 August 2017

Francis Murgatroyd

30

1 reference

Europe PubMed Central

27 August 2017

Samir F Saba

32

1 reference

Europe PubMed Central

27 August 2017

Jerold S Shinbane

33

1 reference

Europe PubMed Central

27 August 2017

Jagmeet Singh

34

1 reference

Europe PubMed Central

27 August 2017

Anthony S Tang

35

1 reference

Europe PubMed Central

27 August 2017

Jose Luis Zamorano

38

1 reference

Europe PubMed Central

27 August 2017

Inder Anand

39

1 reference

Europe PubMed Central

27 August 2017

John P Boehmer

41

1 reference

Europe PubMed Central

27 August 2017

Serge Cazeau

43

1 reference

Europe PubMed Central

27 August 2017

Victoria Delgado

44

1 reference

Europe PubMed Central

27 August 2017

N A Mark Estes

45

1 reference

Europe PubMed Central

27 August 2017

David Haines

46

1 reference

Europe PubMed Central

27 August 2017

Fred Kusumoto

47

1 reference

Europe PubMed Central

27 August 2017

Paco Leyva

48

1 reference

Europe PubMed Central

27 August 2017

Lynne Warner Stevenson

50

1 reference

Europe PubMed Central

27 August 2017

Christian Tobias Torp-Pedersen

51

1 reference

Europe PubMed Central

27 August 2017

publication date

1 September 2012

1 reference

Europe PubMed Central

27 August 2017

1 reference

Europe PubMed Central

27 August 2017

14

1 reference

Europe PubMed Central

27 August 2017

1236-1286

1 reference

Europe PubMed Central

27 August 2017

9

1 reference

Europe PubMed Central

27 August 2017

ACC/AHA/HRS 2008 guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: executive summary

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Indications for cardiac resynchronization therapy: 2011 update from the Heart Failure Society of America Guideline Committee

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the [...]

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Early and sustained effects of cardiac resynchronization therapy on N-terminal pro-B-type natriuretic peptide in patients with moderate to severe heart failure and cardiac dyssynchrony.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Predicting the long-term effects of cardiac resynchronization therapy on mortality from baseline variables and the early response a report from the CARE-HF (Cardiac Resynchronization in Heart Failure) Trial.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Growth differentiation factor-15 predicts mortality and morbidity after cardiac resynchronization therapy

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Cardiac resynchronization in chronic heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Predictors of response to cardiac resynchronization therapy in the Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy (MADIT-CRT).

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

A standardized definition of ischemic cardiomyopathy for use in clinical research

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Device therapy in heart failure patients with chronic kidney disease

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Cardiac resynchronization therapy for the treatment of sleep apnoea: a meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

The Seattle Heart Failure Model: prediction of survival in heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

The prognosis of implantable defibrillator patients treated with cardiac resynchronization therapy: comorbidity burden as predictor of mortality

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Continuous autonomic assessment in patients with symptomatic heart failure: prognostic value of heart rate variability measured by an implanted cardiac resynchronization device.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Reference values for echocardiographic measurements in urban and rural populations of differing ethnicity: the Strong Heart Study

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

The safety of deFinity and Optison for ultrasound image enhancement: a retrospective analysis of 78,383 administered contrast doses

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Cardiac dyssynchrony analysis using circumferential versus longitudinal strain: implications for assessing cardiac resynchronization

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Left ventricular dyssynchrony in patients with left bundle branch block and patients after myocardial infarction: integration of mechanics and viability by cardiac magnetic resonance

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Assessment of residual myocardial viability in regions with chronic electrocardiographic Q-wave infarction

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Left ventricular resynchronization is mandatory for response to cardiac resynchronization therapy: analysis in patients with echocardiographic evidence of left ventricular dyssynchrony at baseline.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

The role of echocardiography in quantification of left ventricular dyssynchrony: state of the art and future directions

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Echocardiographic quantification of left ventricular asynchrony predicts an acute hemodynamic benefit of cardiac resynchronization therapy.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Tailoring cardiac resynchronization therapy using interventricular asynchrony. Validation of a simple model.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Cardiac-resynchronization therapy in heart failure with narrow QRS complexes.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Baseline Doppler parameters are useful predictors of chronic left ventricular reduction in size by cardiac resynchronization therapy.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Echocardiography for cardiac resynchronization therapy: recommendations for performance and reporting--a report from the American Society of Echocardiography Dyssynchrony Writing Group endorsed by the Heart Rhythm Society

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Relation of optimal lead positioning as defined by three-dimensional echocardiography to long-term benefit of cardiac resynchronization

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Impact of left ventricular lead position on the efficacy of cardiac resynchronisation therapy: a two-dimensional strain echocardiography study

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Optimal left ventricular lead position predicts reverse remodeling and survival after cardiac resynchronization therapy

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Practical and conceptual limitations of tissue Doppler imaging to predict reverse remodelling in cardiac resynchronisation therapy.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT).

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Dyssynchrony, contractile function, and response to cardiac resynchronization therapy

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Thebesian valve imaging with electron beam CT angiography: implications for resynchronization therapy.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Detection of small vessels with electron beam computed tomographic angiography using 1.5 and 3 mm collimator protocols.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Noninvasive visualization of the cardiac venous system using multislice computed tomography.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Noninvasive imaging of cardiac venous anatomy with 64-slice multi-slice computed tomography and noninvasive assessment of left ventricular dyssynchrony by 3-dimensional tissue synchronization imaging in patients with heart failure scheduled for card

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Coronary venous aneurysm in patients without cardiac arrhythmia as detected by MDCT: an anatomic variant or a pathologic entity

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Prospective randomized trial of venous cardiac computed tomographic angiography for facilitation of cardiac resynchronization therapy

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Usefulness of multidetector computed tomography coronary venous angiography examination before cardiac resynchronization therapy.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Detection of phrenic nerves and their relation to cardiac anatomy using 64-slice multidetector computed tomography.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Accuracy and usefulness of fusion imaging between three-dimensional coronary sinus and coronary veins computed tomographic images with projection images obtained using fluoroscopy.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Coronary magnetic resonance vein imaging: imaging contrast, sequence, and timing.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Visualization of coronary venous anatomy by cardiovascular magnetic resonance

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Contrast-enhanced whole-heart coronary MRA at 3.0T for the evaluation of cardiac venous anatomy

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Fused whole-heart coronary and myocardial scar imaging using 3-T CMR. Implications for planning of cardiac resynchronization therapy and coronary revascularization.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Magnetic resonance imaging of the cardiac venous system and magnetic resonance-guided intubation of the coronary sinus in swine: a feasibility study

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Magnetic resonance criteria for future trials of cardiac resynchronization therapy

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Intraventricular dyssynchrony predicts mortality and morbidity after cardiac resynchronization therapy: a study using cardiovascular magnetic resonance tissue synchronization imaging.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Delayed enhancement magnetic resonance imaging predicts response to cardiac resynchronization therapy in patients with intraventricular dyssynchrony.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Late gadolinium enhancement-cardiovascular magnetic resonance as a predictor of response to cardiac resynchronization therapy in patients with ischaemic cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Effect of posterolateral left ventricular scar on mortality and morbidity following cardiac resynchronization therapy.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Cardiac resynchronization therapy guided by late gadolinium-enhancement cardiovascular magnetic resonance

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Contrast-enhanced multidetector computed tomography viability imaging after myocardial infarction: characterization of myocyte death, microvascular obstruction, and chronic scar

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Identification and viability assessment of infarcted myocardium with late enhancement multidetector computed tomography: comparison with thallium single photon emission computed tomography and echocardiography

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Early validation study of 64-slice multidetector computed tomography for the assessment of myocardial viability and the prediction of left ventricular remodelling after acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

ACCF/ACR/SCCT/SCMR/ASNC/NASCI/SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriate

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

ACCF/SCCT/ACR/AHA/ASE/ASNC/NASCI/SCAI/SCMR 2010 Appropriate Use Criteria for Cardiac Computed Tomography

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Intra- and interatrial conduction delay: implications for cardiac pacing

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Impact of QRS duration on clinical event reduction with cardiac resynchronization therapy: meta-analysis of randomized controlled trials.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Paced left ventricular QRS width and ECG parameters predict outcomes after cardiac resynchronization therapy: PROSPECT-ECG substudy

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Cardiac-resynchronization therapy for mild-to-moderate heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part III: intraventricular conduction disturbances: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Comm

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Defining left bundle branch block in the era of cardiac resynchronization therapy

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Pacing-induced increase in QT dispersion predicts sudden cardiac death following cardiac resynchronization therapy.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Effect of left ventricular endocardial activation pattern on echocardiographic and clinical response to cardiac resynchronization therapy.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Electrocardiographic imaging of cardiac resynchronization therapy in heart failure: observation of variable electrophysiologic responses

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Perioperative anticoagulation in patients having implantation of a cardiac pacemaker or defibrillator: a systematic review and practical management guide.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Dual antiplatelet therapy and heparin "bridging" significantly increase the risk of bleeding complications after pacemaker or implantable cardioverter-defibrillator device implantation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Pocket hematoma after pacemaker or implantable cardioverter defibrillator surgery: influence of patient morbidity, operation strategy, and perioperative antiplatelet/anticoagulation therapy.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: results of a large prospective study

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Antibiotic prophylaxis for permanent pacemaker implantation: a meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Efficacy of antibiotic prophylaxis before the implantation of pacemakers and cardioverter-defibrillators: results of a large, prospective, randomized, double-blinded, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Elevated defibrillation threshold when right-sided venous access is used for nonthoracotomy implantable defibrillator lead implantation. The Endotak Investigators.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Resumption of sinus rhythm in patients with heart failure and permanent atrial fibrillation undergoing cardiac resynchronization therapy: a longitudinal observational study

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Randomized comparison of defibrillation thresholds from the right ventricular apex and outflow tract.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

A review of the coronary venous system: a road less travelled

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Phrenic stimulation: a challenge for cardiac resynchronization therapy.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Left ventricular pacing with a new quadripolar transvenous lead for CRT: early results of a prospective comparison with conventional implant outcomes

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Use of a quadripolar left ventricular lead to achieve successful implantation in patients with previous failed attempts at cardiac resynchronization therapy.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Long-term retention of cardiac resynchronization therapy.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Effect of resynchronization therapy stimulation site on the systolic function of heart failure patients.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Influence of left ventricular lead location on outcomes in the COMPANION study.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Left ventricular lead position and clinical outcome in the multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy (MADIT-CRT) trial

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Impact of segmental left ventricle lead position on cardiac resynchronization therapy outcomes

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Left ventricular lead electrical delay predicts response to cardiac resynchronization therapy.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

The relationship between ventricular electrical delay and left ventricular remodelling with cardiac resynchronization therapy

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Combined Use of Transesophageal ECHO and Fluoroscopy for the Placement of Left Ventricular Pacing Leads via the Coronary Sinus

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Utilization of intracardiac echocardiography to access the coronary sinus for left ventricular lead placement.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Early human experience with use of a deflectable fiberoptic endocardial visualization catheter to facilitate coronary sinus cannulation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Direct visualization of coronary sinus ostium and branches with a flexible steerable fiberoptic infrared endoscope.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

A mechanism for immediate reduction in mitral regurgitation after cardiac resynchronization therapy: insights from mechanical activation strain mapping.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Acute effects of cardiac resynchronization therapy on functional mitral regurgitation in advanced systolic heart failure.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Velocity vector imaging to quantify ventricular dyssynchrony and predict response to cardiac resynchronization therapy

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Novel speckle-tracking radial strain from routine black-and-white echocardiographic images to quantify dyssynchrony and predict response to cardiac resynchronization therapy.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Integrating functional and anatomical information to guide cardiac resynchronization therapy

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Variable left ventricular activation pattern in patients with heart failure and left bundle branch block

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Epicardial left ventricular lead placement for cardiac resynchronization therapy: optimal pace site selection with pressure-volume loops.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Canadian Registry of ICD Implant Testing procedures (CREDIT): current practice, risks, and costs of intraoperative defibrillation testing

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Left ventricular endocardial stimulation for severe heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Effect of triangle ventricular pacing on haemodynamics and dyssynchrony in patients with advanced heart failure: a comparison study with conventional bi-ventricular pacing therapy.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Successful 'quadrangular' pacing in a non-responder patient to cardiac resynchronization therapy.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Radiographic left ventricular-right ventricular interlead distance predicts the acute hemodynamic response to cardiac resynchronization therapy.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Targeted left ventricular lead placement to guide cardiac resynchronization therapy: the TARGET study: a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Impact of viability and scar tissue on response to cardiac resynchronization therapy in ischaemic heart failure patients.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Influence of pacing configurations, body mass index, and position of coronary sinus lead on frequency of phrenic nerve stimulation and pacing thresholds under cardiac resynchronization therapy.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Left ventricular lead implantation at a phrenic stimulation site is safe and effective.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Six year experience of transvenous left ventricular lead implantation for permanent biventricular pacing in patients with advanced heart failure: technical aspects

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

A comparison of pectoral and abdominal transvenous defibrillator implantation: analysis of costs and outcomes.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Optimization of superior vena cava coil position and usage for transvenous defibrillation.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Prospective randomized comparison of two defibrillation safety margins in unipolar, active pectoral defibrillator therapy.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

The dilemma of ICD implant testing

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Defibrillation testing at the time of implantable cardioverter defibrillator implantation: results of the European Heart Rhythm Association survey

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Defibrillation testing at the time of ICD insertion: an analysis from the Ontario ICD Registry

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

No benefit from defibrillation threshold testing in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial).

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Elevated defibrillation thresholds in patients undergoing biventricular defibrillator implantation: incidence and predictors.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Delayed defibrillation testing in patients implanted with biventricular ICD (CRT-D): a reliable and safe approach.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Subclavian venoplasty by the implanting physicians in 373 patients over 11 years

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Is there an adverse outcome from abandoned pacing leads?

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

From lead management to implanted patient management: indications to lead extraction in pacemaker and cardioverter-defibrillator systems

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Safety and acceptability of implantation of internal cardioverter-defibrillators under local anesthetic and conscious sedation.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Pacemaker and internal cardioverter defibrillator lead extraction: a safe and effective surgical approach

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Long-term effectiveness of cardiac resynchronization therapy in heart failure patients with unfavorable cardiac veins anatomy comparison of surgical versus hemodynamic procedure

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Comparison of the efficacy of two surgical alternatives for cardiac resynchronization therapy: trans-apical versus epicardial left ventricular pacing

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Implant venoplasty: dilation of subclavian and coronary veins to facilitate device implantation: indications, frequency, methods, and complications

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Efficacy of coronary venoplasty for left ventricular lead implantation.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Prolonged inflation of coronary angioplasty balloon as treatment for subocclusive dissection of the coronary sinus during implantation of a coronary sinus pacing lead.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Rescue-stenting of an occluded lateral coronary sinus branch for recanalization after dissection during cardiac resynchronization device implantation.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Coronary vein rupture during venoplasty for LV lead placement.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Guidelines for cardiac pacing and cardiac resynchronization therapy. The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Acute lead dislodgements and in-hospital mortality in patients enrolled in the national cardiovascular data registry implantable cardioverter defibrillator registry

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Chest radiography is a poor predictor of left ventricular lead position in patients undergoing cardiac resynchronization therapy: comparison with multidetector computed tomography

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Significance of QRS complex duration in patients with heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Electrocardiographic follow-up of biventricular pacemakers.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

An algorithm for verifying biventricular capture based on evoked-response morphology.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

An electrocardiogram-based algorithm to detect loss of left ventricular capture during cardiac resynchronization therapy.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Right atrial pacing impairs cardiac function during resynchronization therapy: acute effects of DDD pacing compared to VDD pacing.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Primary results from the SmartDelay determined AV optimization: a comparison to other AV delay methods used in cardiac resynchronization therapy (SMART-AV) trial: a randomized trial comparing empirical, echocardiography-guided, and algorithmic atrio

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Does cardiac resynchronization therapy provide unrecognized benefit in patients with prolonged PR intervals? The impact of restoring atrioventricular synchrony: an analysis from the COMPANION Trial

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Surface electrocardiogram to predict outcome in candidates for cardiac resynchronization therapy: a sub-analysis of the CARE-HF trial

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Effect of optimizing the VV interval on left ventricular contractility in cardiac resynchronization therapy.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Relationship between improvement in left ventricular dyssynchrony and contractile function and clinical outcome with cardiac resynchronization therapy: the MADIT-CRT trial.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Implantation of cardiac resynchronization therapy systems in the CARE-HF trial: procedural success rate and safety.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Cardiac-resynchronization therapy for the prevention of heart-failure events.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

The management of surgical complications of pacemaker and implantable cardioverter-defibrillators

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

What can happen during coronary sinus lead implantation: dislocation, perforation and other catastrophes.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Contrast nephropathy post cardiac resynchronization therapy: an under-recognized complication with important morbidity.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

First-degree atrioventricular block. Clinical manifestations, indications for pacing, pacemaker management & consequences during cardiac resynchronization.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Heart failure decompensation and all-cause mortality in relation to percent biventricular pacing in patients with heart failure: is a goal of 100% biventricular pacing necessary?

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Long-term survival in patients undergoing cardiac resynchronization therapy: the importance of performing atrio-ventricular junction ablation in patients with permanent atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Blanked atrial flutter in patients with cardiac resynchronization therapy: clinical significance and implications for device programming.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Long-term outcome after ICD and CRT implantation and influence of remote device follow-up: the ALTITUDE survival study

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Efficacy and safety of automatic remote monitoring for implantable cardioverter-defibrillator follow-up: the Lumos-T Safely Reduces Routine Office Device Follow-up (TRUST) trial.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Trial design of the clinical evaluation of remote notification to reduce time to clinical decision: the Clinical evaluation Of remote NotificatioN to rEduCe Time to clinical decision (CONNECT) study.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Clinical benefits of remote versus transtelephonic monitoring of implanted pacemakers

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

A randomized trial of long-term remote monitoring of pacemaker recipients (the COMPAS trial).

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients Wit

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Intrathoracic impedance vs daily weight monitoring for predicting worsening heart failure events: results of the Fluid Accumulation Status Trial (FAST).

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Device therapy and hospital reimbursement practices across European countries: a heterogeneous scenario

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Implantable CRT device diagnostics identify patients with increased risk for heart failure hospitalization.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Relationship of paroxysmal atrial tachyarrhythmias to volume overload: assessment by implanted transpulmonary impedance monitoring.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Sensitivity and positive predictive value of implantable intrathoracic impedance monitoring as a predictor of heart failure hospitalizations: the SENSE-HF trial

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Physician-directed patient self-management of left atrial pressure in advanced chronic heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

16-year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States 1993 to 2008.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Long-term complications related to biventricular defibrillator implantation: rate of surgical revisions and impact on survival: insights from the Italian Clinical Service Database

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Complications leading to surgical revision in implantable cardioverter defibrillator patients: comparison of patients with single-chamber, dual-chamber, and biventricular devices

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Implantation-related complications of implantable cardioverter-defibrillators and cardiac resynchronization therapy devices: a systematic review of randomized clinical trials

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Non-responders to cardiac resynchronization therapy: the magnitude of the problem and the issues

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Selection of endpoints for heart failure clinical trials

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

The effect of cardiac resynchronization on morbidity and mortality in heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Comparison of efficacy of reverse remodeling and clinical improvement for relatively narrow and wide QRS complexes after cardiac resynchronization therapy for heart failure.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Usefulness of echocardiographic tissue synchronization imaging to predict acute response to cardiac resynchronization therapy.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Tissue Doppler imaging is superior to strain rate imaging and postsystolic shortening on the prediction of reverse remodeling in both ischemic and nonischemic heart failure after cardiac resynchronization therapy.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

A novel tool to assess systolic asynchrony and identify responders of cardiac resynchronization therapy by tissue synchronization imaging.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Tissue Doppler velocity is superior to displacement and strain mapping in predicting left ventricular reverse remodelling response after cardiac resynchronisation therapy

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Utility of echocardiographic radial strain imaging to quantify left ventricular dyssynchrony and predict acute response to cardiac resynchronization therapy.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Effect of total scar burden on contrast-enhanced magnetic resonance imaging on response to cardiac resynchronization therapy.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Combined longitudinal and radial dyssynchrony predicts ventricular response after resynchronization therapy.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Effect of lateral wall scar on reverse remodeling with cardiac resynchronization therapy

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Results of the Prospective Minnesota Study of ECHO/TDI in Cardiac Resynchronization Therapy (PROMISE-CRT) study

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Clinical and echocardiographic correlates of improvement in left ventricular diastolic function after cardiac resynchronization therapy.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Combined assessment of left ventricular dyssynchrony and contractility by speckled tracking strain imaging: a novel index for predicting responders to cardiac resynchronization therapy.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Multi-plane mechanical dyssynchrony in cardiac resynchronization therapy.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Presence of left ventricular contractile reserve predicts midterm response to cardiac resynchronization therapy--results from the LOw dose DObutamine stress-echo test in Cardiac Resynchronization Therapy (LODO-CRT) trial

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

QRS duration and shortening to predict clinical response to cardiac resynchronization therapy in patients with end-stage heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Comparison of characteristics in responders versus nonresponders with biventricular pacing for drug-resistant congestive heart failure.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Comparison of benefits from cardiac resynchronization therapy in patients with ischemic cardiomyopathy versus idiopathic dilated cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Can LV dyssynchrony as assessed with phase analysis on gated myocardial perfusion SPECT predict response to CRT?

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Predictors of lack of response to resynchronization therapy.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Clinical and electrocardiographic predictors of a positive response to cardiac resynchronization therapy in advanced heart failure.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Ventricular asynchrony predicts a better outcome in patients with chronic heart failure receiving cardiac resynchronization therapy.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Decreased likelihood of response to cardiac resynchronization in patients with severe heart failure.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Dyssynchrony by speckle-tracking echocardiography and response to cardiac resynchronization therapy: results of the Speckle Tracking and Resynchronization (STAR) study.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Assessment of response criteria to cardiac resynchronization therapy (CRT) and prediction of response.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Relationship between left ventricular lead position using a simple radiographic classification scheme and long-term outcome with resynchronization therapy.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Effect of left ventricular lead concordance to the delayed contraction segment on echocardiographic and clinical outcomes after cardiac resynchronization therapy.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Triple-site biventricular pacing in patients undergoing cardiac resynchronization therapy: a feasibility study.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

A randomized comparison of triple-site versus dual-site ventricular stimulation in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Addition of a second LV pacing site in CRT nonresponders rationale and design of the multicenter randomized V(3) trial.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Comparison of chronic biventricular pacing between epicardial and endocardial left ventricular stimulation using Doppler tissue imaging in patients with heart failure.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Transseptal endocardial left ventricular pacing: an alternative technique for coronary sinus lead placement in cardiac resynchronization therapy.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Left ventricular endocardial pacing in cardiac resynchronisation therapy: Moving from bench to bedside

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

A novel approach for endocardial resynchronization therapy: initial experience with transapical implantation of the left ventricular lead.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

The utility of 12-lead Holter monitoring in patients with permanent atrial fibrillation for the identification of nonresponders after cardiac resynchronization therapy

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Left ventricular systolic dysfunction by itself does not influence outcome of atrial fibrillation ablation.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Radiofrequency ablation for persistent atrial fibrillation in patients with advanced heart failure and severe left ventricular systolic dysfunction: a randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Pulmonary-vein isolation for atrial fibrillation in patients with heart failure.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Radiofrequency catheter ablation of premature ventricular complexes improved left ventricular function in a non-responder to cardiac resynchronization therapy.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Intrathoracic impedance monitoring, audible patient alerts, and outcome in patients with heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Outcomes of cardiac resynchronization therapy in patients with versus those without atrial fibrillation: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Cardiac resynchronization in patients with congestive heart failure and chronic atrial fibrillation: effect of upgrading to biventricular pacing after chronic right ventricular pacing.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Cardiac resynchronization therapy in patients undergoing atrioventricular junction ablation for permanent atrial fibrillation: a randomized trial.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Atrial fibrillation burden during the post-implant period after crt using device-based diagnostics.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Burden of atrial fibrillation after cardiac resynchronization therapy.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Review of the registry's fourth year, incorporating lead data and pediatric ICD procedures, and use as a national performance measure.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

More is better with cardiac resynchronization therapy--but is it enough?

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase].

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Heart failure and sudden death in patients with tachycardia-induced cardiomyopathy and recurrent tachycardia

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

The European CRT Survey: 1 year (9-15 months) follow-up results.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

HRS Expert Consensus Statement on the Management of Cardiovascular Implantable Electronic Devices (CIEDs) in patients nearing end of life or requesting withdrawal of therapy

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

EHRA Expert Consensus Statement on the management of cardiovascular implantable electronic devices in patients nearing end of life or requesting withdrawal of therapy

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Telemonitoring with implantable electronic devices in young patients with congenital heart diseases

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

The long-term cost-effectiveness of cardiac resynchronization therapy with or without an implantable cardioverter-defibrillator.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Cost-effectiveness of cardiac resynchronization therapy: results from the CARE-HF trial.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Cost-effectiveness of cardiac resynchronization therapy in patients with asymptomatic to mild heart failure: insights from the European cohort of the REVERSE (Resynchronization Reverses remodeling in Systolic Left Ventricular Dysfunction).

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

2010 Focused Update of ESC Guidelines on device therapy in heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Effect of Posterolateral Scar Tissue on Clinical and Echocardiographic Improvement After Cardiac Resynchronization Therapy

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Left Ventricular Dyssynchrony Predicts Right Ventricular Remodeling After Cardiac Resynchronization Therapy

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Cardiac MRI to investigate myocardial scar and coronary venous anatomy using a slow infusion of dimeglumine gadobenate in patients undergoing assessment for cardiac resynchronization therapy

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Magnetic resonance imaging and response to cardiac resynchronization therapy: relative merits of left ventricular dyssynchrony and scar tissue

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Analysis of Ventricular Activation Using Surface Electrocardiography to Predict Left Ventricular Reverse Volumetric Remodeling During Cardiac Resynchronization Therapy

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Optimizing Hemodynamics in Heart Failure Patients by Systematic Screening of Left Ventricular Pacing Sites

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Exercise stress echocardiography is superior to rest echocardiography in predicting left ventricular reverse remodelling and functional improvement after cardiac resynchronization therapy

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Left ventricular dyssynchrony predicts benefit of cardiac resynchronization therapy in patients with end-stage heart failure before pacemaker implantation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Comparison of response to cardiac resynchronization therapy in patients with sinus rhythm versus chronic atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Left Ventricular Endocardial Pacing Improves Resynchronization Therapy in Canine Left Bundle-Branch Hearts

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Endocardial Left Ventricular Pacing Improves Cardiac Resynchronization Therapy in Chronic Asynchronous Infarction and Heart Failure Models

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Correction of Mitral Regurgitation in Nonresponders to Cardiac Resynchronization Therapy by MitraClip Improves Symptoms and Promotes Reverse Remodeling

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Non-contrast magnetic resonance imaging for guiding left ventricular lead position in cardiac resynchronization therapy

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Cardiac resynchronization therapy and the relationship of percent biventricular pacing to symptoms and survival

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

A randomized double-blind comparison of biventricular versus left ventricular stimulation for cardiac resynchronization therapy: the Biventricular versus Left Univentricular Pacing with ICD Back-up in Heart Failure Patients (B-LEFT HF) trial

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Real World Evaluation of Dual-Zone ICD and CRT-D Programming Compared to Single-Zone Programming: The ALTITUDE REDUCES Study

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Triple-Site Versus Standard Cardiac Resynchronization Therapy Study (TRUST CRT): Clinical Rationale, Design, and Implementation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Prediction of Mode of Death in Heart Failure

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS222

21 January 2018

Identifiers

10.1093/EUROPACE/EUS222

1 reference

Europe PubMed Central

27 August 2017

1 reference

Europe PubMed Central

27 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38038846&oldid=2002069320"